Filing Flows › Neogen (NEOG) › Recalls, complaints & regulation
Neogen (NEOG): recalls
Neogen (NEOG) beyond its filings: 0 recalls in the last 12 months (2 in five years, 0 Class I).
Latest recalls
- 2024-12-04 · FDA drug · LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varin
- 2024-12-04 · FDA drug · LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Va
Neogen's latest quarter
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart follows the revenue to costs, profit and cash.
Questions
Has Neogen had any recalls?
2 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.